Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R James White

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Study of Risk Assessment Scores as Surrogate Endpoints in Pulmonary Arterial Hypertension TrialsYongqi Liu, R James White, Sang Wan Lee, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 30, 2016
Transition from parenteral to oral treprostinil in pulmonary arterial hypertensionMurali M Chakinala, Jeremy P Feldman, Franz Rischard, et al.
Geriatric Orthopaedic Surgery & Rehabilitation|April 10, 2013
Hip fracture in a patient with severe pulmonary hypertensionSusan M Friedman, R James White, Steven M Finkelstein, et al.
Pulmonary Circulation|October 5, 2020
Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolusDaniel Lachant, Christina Bach, Bennett Wilson, et al.
Journal of Managed Care & Specialty Pharmacy|February 14, 2018
Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United StatesCharles D Burger, A Burak Ozbay, Howard M Lazarus, et al.
Annals of the American Thoracic Society|April 13, 2026
Rodatristat Ethyl Decreases Activity in Pulmonary Arterial Hypertension: Results from the ELEVATE-2 TrialDaniel J Lachant, Sandeep Sahay, Robert Block, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 20, 2019
Combination therapy improves vascular volume in female rats with pulmonary hypertensionDaniel J Lachant, David F Meoli, Deborah Haight, et al.
Journal of Cardiovascular Pharmacology|January 19, 2013
Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertensionR James White, Fernando Torres, Roblee Allen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 22, 2009
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trialJagdish Hiremath, Sadagopa Thanikachalam, Keyur Parikh, et al.
Seminars in Arthritis and Rheumatism|September 19, 2024
Utility of factor D and other alternative complement factors as biomarkers in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH)Eva Petrow, Changyong Feng, Ashley Frazer-Abel, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Study of Risk Assessment Scores as Surrogate Endpoints in Pulmonary Arterial Hypertension TrialsYongqi Liu, R James White, Sang Wan Lee, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 30, 2016
Transition from parenteral to oral treprostinil in pulmonary arterial hypertensionMurali M Chakinala, Jeremy P Feldman, Franz Rischard, et al.
Geriatric Orthopaedic Surgery & Rehabilitation|April 10, 2013
Hip fracture in a patient with severe pulmonary hypertensionSusan M Friedman, R James White, Steven M Finkelstein, et al.
Pulmonary Circulation|October 5, 2020
Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolusDaniel Lachant, Christina Bach, Bennett Wilson, et al.
Journal of Managed Care & Specialty Pharmacy|February 14, 2018
Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United StatesCharles D Burger, A Burak Ozbay, Howard M Lazarus, et al.
Annals of the American Thoracic Society|April 13, 2026
Rodatristat Ethyl Decreases Activity in Pulmonary Arterial Hypertension: Results from the ELEVATE-2 TrialDaniel J Lachant, Sandeep Sahay, Robert Block, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 20, 2019
Combination therapy improves vascular volume in female rats with pulmonary hypertensionDaniel J Lachant, David F Meoli, Deborah Haight, et al.
Journal of Cardiovascular Pharmacology|January 19, 2013
Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertensionR James White, Fernando Torres, Roblee Allen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 22, 2009
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trialJagdish Hiremath, Sadagopa Thanikachalam, Keyur Parikh, et al.
Seminars in Arthritis and Rheumatism|September 19, 2024
Utility of factor D and other alternative complement factors as biomarkers in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH)Eva Petrow, Changyong Feng, Ashley Frazer-Abel, et al.
Pageof 7